It followed a 12% gain in 2Q.
Pharmaceuticals distributor Cardinal Health reported its 2024 third quarter financial results on May 2, showing continued strong annual sales gains while its net profit saw a major decline largely due to a change in its reporting structure.
The Dublin, OH-based company posted total 3Q sales of $54.9 billion, up 9% year-over-year, following 2Q’s 12% gain.
Cardinal Health had a 3Q operating profit of $367 million that sunk 36% year-over-year, while net profit of $258 million likewise fell 25%. Those figures were skewed by a $90 million imaprtment charge related to the company’s Global Medical Products and Distribution segment resulting from the reallocation of goodwill related to a reporting structure update.
By Cardinal Health business segment in 3Q:
- Pharmaceutical and Specialty Solutions sales of $50.7 billion increased 9% year-over-year, while segment profit of $580 million increased 4%.
- Global Medical Products and Distribution sales of $3.1 billion increased 4% year-over-year, with segment profit of $20 million reversing a $46 million loss of a year earlier.
On April 2, Cardinal Health announced it began to build of a 350,000-square-foot logistics center in Columbus, OH, which will serve as a centralized replenishment center for the distribution of over-the-counter consumer health products in support of its core pharmaceutical business.
Related Posts
-
To support demand for consumer health products, Cardinal Health’s new facility will be the central…
-
The company posted 3Q year-over-year sales growth of 5.4%, an impressive rebound from the 3.6%…
-
Sales sequentially decelerated further amid what the company cited as economic softness and lower market…
Share this article
Log In
Read the latest articles and see your reports.
Popular Now
MDM Directories
Sign Up for the MDM Update Newsletter
The MDM update newsletter is your best source for news and trends in the wholesale distribution industry.
Leave a Comment
You must be logged in to post a comment.